MENLO PARK, Calif., March 07, 2017 -- Landec Corporation (NASDAQ:LNDC), a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets, announced today that the Company's recently acquired business, O Olive Oil, Inc. ("O Olive"), will participate at the Natural Products Expo West trade show. Landec's President and Chief Executive Officer Molly Hemmeter will be joining Greg Hinson, Founder and President of O Olive, along with other Company representatives from Landec and Apio at the largest natural, organic and healthy products conference in the world.
The Natural Products Expo West 2017 trade show will be held from March 8, 2017 to March 12, 2017 at the Anaheim Convention Center in Anaheim, CA. It is the leading trade show in the natural, organic and healthy products industry and was rated as one of the top 200 trade shows in the United States by Tradeshow Week. More than 3,000 exhibitors from nearly 125 different countries participated in last year's event. Last year, more than 75,000 visitors attended the event, up from just 3,000 visitors at its inaugural event in 1981.
As previously reported on March 1, 2017, Landec entered into a definitive agreement to purchase O Olive. The Company was founded in 1995, is based in Petaluma, California, and is the premier producer of California specialty olive oils and wine vinegars. O Olive has been honored with 17 SOFI awards by the Specialty Food Association, more than any other oil and vinegar company in the world. Its products are sold in over 4,600 natural food, conventional grocery and mass retail stores, primarily in the United States and Canada.
For additional information on O Olive, please visit their website at: www.ooliveoil.com
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets. Apio, Landec’s food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
Contact Information: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: John Mills, Partner (646) 277-1254 [email protected]


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 



